Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Abdullah, Buyukcelik"'
Publikováno v:
Medicine Science, Vol 3, Iss 4, Pp 1639-47 (2014)
Glioblastoma Multiforme (GBM) is the most common type of primary brain tumor and its prognosis is poor. Some studies have investigated the relationship between ABO Blood Groups and cancer risk. In this study we evaluated the patients with GBM and con
Externí odkaz:
https://doaj.org/article/7d897ce1f9214c63b8228bd26bf00c24
Autor:
Hasan Mutlu, Zeki Akca, Yasemin Benderli Cihan, Tuncay Aslan, Abdulsamet Erden, Abdullah Buyukcelik
Publikováno v:
Medicine Science, Vol 2, Iss 3, Pp 757-63 (2013)
The complementary and alternative medicine (CAM) are commonly encountered by cancer patients. In this study, the methods of CAM used by Turkish cancer patients were documented, and its frequency and the changes in the use of CAM over time were evalua
Externí odkaz:
https://doaj.org/article/e704197305364de58705cf56318d20d6
Autor:
Hasan Mutlu, Halit Karaca, Zeki Akca, Yasemin Altuner Torun, Abdulsamet Erden, Tuncay Aslan, Abdullah Buyukcelik
Publikováno v:
Medicine Science, Vol 2, Iss 2, Pp 539-47 (2013)
CerbB2 receptor determination is very important for the prognosis and treatment of breast cancer. The most used two methods for CerbB2 receptor determination are immunohistochemistry and FISH methods. FISH method is recommended for immunohistochemica
Externí odkaz:
https://doaj.org/article/a43b6c5f532a48bdbc51934fcc87e0fc
Publikováno v:
Japanese journal of clinical oncology. 40(10)
Docetaxel (Taxotere), an anticancer agent, is known to cause various reactions, including hypersensitivity, oedema, skin toxicity with erythrodysesthesia syndrome, infusion site reactions, alopecia, nail onycholysis, nail pigmentation, photosensitivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0436104bb0d9fe91225148bd2778b3
https://pubmed.ncbi.nlm.nih.gov/20522447
https://pubmed.ncbi.nlm.nih.gov/20522447
Autor:
Ozdemir, Feyyaz, Icli, Fikri, Yalcin, Bulent, Isikdogan, Abdurrahman, ÇELİK, İSMAİL, Unsal, Diclehan, Coskun, Senol, Abdullah, Buyukcelik, Yamac, Deniz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10046::d29dcd797946ff3e0317b74f3ed9c0d3
https://avesis.gazi.edu.tr/publication/details/fa309983-8729-42d2-9b30-9aea0f4a565a/oai
https://avesis.gazi.edu.tr/publication/details/fa309983-8729-42d2-9b30-9aea0f4a565a/oai
Autor:
Abdullah, Buyukcelik, Yalcin, Bulent, Gungor, Utkan, Fikri, Icli, Umman, Sanlidilek, Hakan, Akbulut
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 12(9)
The increased tendency to thromboembolism in cancer patient has been recognized for a long time. However, arterial thromboembolism and thrombosis of the pulinonary artery have rarely been reported. Pulmonary thromboembolism is usually a complication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c26d7d8dd60824f3d63d1e343bd27a37
https://pubmed.ncbi.nlm.nih.gov/16940937
https://pubmed.ncbi.nlm.nih.gov/16940937
Autor:
Bulent, Yalcin, Ali, Pamir, Abdullah, Buyukcelik, Gungor, Utkan, Hakan, Akbulut, Ahmet, Demirkazik, Fikri, Icli
Publikováno v:
Experimental oncology. 26(4)
Ifosfamide and doxorubicin are the most effective agents in the treatment of sarcomas, although their contributions to survival are usually limited. High-dose ifosfamide can be used as a salvage treatment in patients with recurrent or advanced sarcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::859619de8299514e52b7e3d089c9adbd
https://pubmed.ncbi.nlm.nih.gov/15627067
https://pubmed.ncbi.nlm.nih.gov/15627067
Autor:
Hakan, Akbulut, Fikri, Icli, Bulent, Yalcin, Ahmet, Demirkazik, Handan, Onur, Abdullah, Buyukcelik, Gungor, Utkan
Publikováno v:
Experimental oncology. 26(2)
Irinotecan is an active drug after fluorouracil (FU) failure in patients with colorectal cancer (CRC). Also a modest activity of cisplatin and dacarbazine combination in FU resistant patients have been reported. We aimed to assess the efficacy of iri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ca8cab295dd28c32a9fdd6ab03b5486
https://pubmed.ncbi.nlm.nih.gov/15273666
https://pubmed.ncbi.nlm.nih.gov/15273666
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.